The Patent Finder

Terms ending in 2031

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,029,377Platelet-Activating Factor Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,278,304Substituted 4-Hydroxypyrimidine-5-Carboxamides
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,394,819Indole Derivatives as CRTH2 Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,603,998Novel Modulators of Cell Cycle Checkpoints and Their Use in Combination with Checkpoint Kinase Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,513,234HIV Integrase Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US D777,907Medical Injector Pen
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US D777,908Medical Injector Device
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,192,74615-Valent Pneumococcal Polysaccharide-Protein Conjugate Vaccine Composition
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,394,969Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,796,452Preparation of Lamivudine Form I
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
143 more term ends in 2031 · Pro
10 of 153 patents shown. Soonest term end first, then patent number.
Pro members see all 153.
Upgrade to Pro
109 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited